High Interest From VC Forums in Atlanta Catheter Therapies

ATLANTA, GA–(Marketwire – October 25, 2010) –  Medical device company Atlanta Catheter Therapies, Inc. (ACT) is generating high interest in its innovative intravascular catheterization which integrates drug delivery. The company has been selected to present at the upcoming 14^th Annual Tennessee Valley Venture Forum (TVVF) as well as the Southeast BIO (SEBIO) Investor Forum.

The TVVF will be held October 27 at the Crowne Plaza in Knoxville, Tennessee. Southeast BIO (SEBIO) Investor Forum being held November 3-4, 2010 at the Ritz-Carlton Buckhead in Atlanta, Georgia.

ACT is focused on developing innovative catheter technologies for the treatment of vascular disease and restenosis. ACT’s lead product, an innovative catheter that integrates drug delivery with vascular catheterization, has completed the prototyping phase.

The Occlusion Perfusion Catheter™ (OPC) allows endovascular specialists who have already cleared blocked blood vessels to then immediately circumferentially infuse the media with an agent or live cell to reduce or eliminate restenosis (re-blockage). The OPC follows the same guide wire used by the debulking catheter to deliver anti-restenosis agents or drugs and other therapies directly and precisely to the treatment site.

In addition to the OPC, the company is attacking the problem of vascular disease by developing leading edge technology for atherectomy, thrombectomy and other catheter-based devices. ACT currently has seven devices in its product development pipeline, including the OPC.

Southeast BIO (SEBIO) is a regional nonprofit organization dedicated to fostering the growth of the Southeast’s life sciences industry. Presenting companies, which represent the best life science deals in the Southeast, are determined by a Selection Committee comprised of regional and national venture capitalists. Since 1999, companies that have participated in the SEBIO Investor Forum have raised over $2.5 billion in public and private offerings, making it the region’s most successful venue for linking industry investors with the Southeast’s top life sciences companies.

About Atlanta Catheter Therapies
Atlanta Catheter Therapies is an early stage research and development medical device company with an innovative and targeted portfolio of catheter technologies for the treatment of vascular disease and restenosis. Learn more at www.atlcath.com.

Click here to see all recent news from this company